"Andreas Lazar" . "21209123" . . "scientific article published on 05 January 2011"@en . . . . "Stefan Schreiber" . . . . . . . "article scientifique publi\u00E9 en 2011"@fr . . . . "wetenschappelijk artikel"@nl . "\u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E 2011 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0570\u0578\u0582\u0576\u057E\u0561\u0580\u056B 5-\u056B\u0576"@hy . . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@en . "10.1136/GUT.2010.221127" . . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@nl . "2011-01-05T00:00:00Z"^^ . "Daniel W Hommes" . "780-787" . . . . . . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@en . . "im Januar 2011 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . "60" . . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@nl . "Bidan Huang" . . . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@en . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@nl . "Wendy Kampman" . . "6" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 2011"@uk . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xineru de 2011"@ast . . "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial"@en . . . . . . . .